Probing Amyloid β Interactions with Synthetic Heparan Sulfate Oligosaccharides
- 16 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 16 (10) , 1894-1899
Abstract
Heparan sulfate (HS) can play important roles in the biology and pathology of amyloid β (Aβ), a hallmark of Alzheimer’s disease. To better understand the structure–activity relationship of HS/Aβ interactions, synthetic HS oligosaccharides ranging from tetrasaccharides to decasaccharides have been utilized to study Aβ interactions. Surface plasmon resonance experiments showed that the highly sulfated HS tetrasaccharides bearing full 2-O, 6-O, and N-sulfations exhibited the strongest binding with Aβ among the tetrasaccharides investigated. Elongating the glycan length to hexa- and deca-saccharides significantly enhanced Aβ affinity compared to the corresponding HS tetrasaccharide. Solid state NMR studies of the complexes of Aβ with HS hexa- and deca-saccharides showed most significant chemical shift perturbation in the C-terminus residues of Aβ. The strong binding HS oligosaccharides could reduce the cellular toxicities induced by Aβ. This study provides new insights into HS/Aβ interactions, highlighting how synthetic structurally well-defined HS oligosaccharides can assist in biological understanding of Aβ.Keywords
Funding Information
- U.S. Department of Health and Human Services (R01GM072667)
This publication has 29 references indexed in Scilit:
- 2020 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2020
- Contribution of syndecans to cellular internalization and fibrillation of amyloid-β(1–42)Scientific Reports, 2019
- Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregationBiophysical Reviews, 2017
- Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s diseaseScience Translational Medicine, 2016
- Towards Understanding the Roles of Heparan Sulfate Proteoglycans in Alzheimer’s DiseaseBioMed Research International, 2014
- Heparan sulfate mediates amyloid-beta internalization and cytotoxicityGlycobiology, 2010
- Alzheimer's Disease: Another Target for Heparin TherapyThe Scientific World Journal, 2009
- Heparan Sulfate Accumulation with Aβ Deposits in Alzheimer's Disease and Tg2576 Mice is Contributed by Glial CellsBrain Pathology, 2008
- 2003 Claude S. Hudson Award Address in Carbohydrate Chemistry. Heparin: Structure and ActivityJournal of Medicinal Chemistry, 2003
- A General Practice Trial of Ateroid 200 in 8,776 Patients with Chronic Senile Cerebral Insufficiency1989